The U.S. Food and Drug Administration (FDA) has agreed to review an application from Roche seeking approval of its BTK inhibitor fenebrutinib as a treatment for relapsing forms of both multiple sclerosis (MS) and primary progressive MS (PPMS). Further, the FDA granted the application priority review, under…
Discussion
An estimated 3.1 million people worldwide are now living with multiple sclerosis (MS), up from about 2.8 million in 2020, according to the latest update of the Multiple Sclerosis International Federation’s Atlas of MS. The new estimate means that global MS prevalence — the number of people living…
Discussion
With multiple sclerosis (MS), pain can sometimes be obvious, and sometimes it is something I carry quietly while I go about my day. From the outside, I might look fine. I can have a conversation, answer emails, laugh with someone, or get through everything I need to do, but…
Discussion
An experimental therapy called kamuvudine-9 (K-9) reversed established paralysis and vision loss in a mouse model of multiple sclerosis (MS), offering hope for treatments that can restore lost function rather than just prevent future damage. “Most MS therapies are aimed at preventing the next attack. What’s remarkable is…
Discussion
A digital lifestyle program promoting a balanced diet, regular physical activity, better sleep, and stress management was associated with improvements in several measures and behaviors reported by people with multiple sclerosis (MS), a study found. Most gains emerged during the intensive three-month program. Over the next 21 months, improvements…
Get regular updates to your inbox.
